Gene | Description | 4-OHT (RQ) | BD (RQ) | Combination (RQ) |
---|---|---|---|---|
BRAF | serine/threonine-protein kinase B-Raf | 2.91 ± 0.55* | 1.85 ± 0.10 | 5.27 ± 0.82* |
PTK2B | protein tyrosine kinase 2 beta | 2.76 ± 0.62 | 2.25 ± 1.33 | 4.51 ± 1.41* |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21) | 1.06 ± 0.14 | 3.26 ± 0.28* | 4.06 ± 0.22* |
NFKBIA | NF-kappa-B inhibitor | 1.86 ± 0.50 | 2.35 ± 0.33* | 3.42 ± 0.16* |
FYN | FYN oncogene related to SRC, FGR, YES | 1.81 ± 0.34 | 2.36 ± 0.81 | 3.16 ± 0.81* |
CASP9 | caspase 9 | 2.04 ± 0.33 | 1.67 ± 0.16 | 2.67 ± 0.67* |
BCL2 | B-cell CLL/lymphoma 2 | 0.13 ± 0.10* | 0.29 ± 0.23* | 0.08 ± 0.05* |
CCND2 | cyclin D2 | 0.39 ± 0.08* | 0.12 ± 0.10* | 0.10 ± 0.10* |
FN1 | fibronectin 1 | 0.41 ± 0.04* | 0.30 ± 0.09* | 0.19 ± 0.11* |
ITGA2B | integrin, alpha 2b | 0.62 ± 0.12* | 0.58 ± 0.20* | 0.41 ± 0.12* |